REQUEST A DEMO
Total
USD $0.00
Search more companies

G.V.Pharma, A.S. (Slovakia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: G.V.Pharma, A.S. Profile Updated: October 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

G.V.Pharma, A.S. is an enterprise in Slovakia, with the main office in Hlohovec. It operates in the Pharmaceutical Preparation Manufacturing industry. The enterprise was incorporated on June 09, 1995. 25 - 49 (2023) employees currently work for G.V.Pharma, A.S.. From the latest financial highlights, G.V.Pharma, A.S. reported a net sales revenue increase of 145.8% in 2023. Over the same period, its total assets grew by 14.27%.

Headquarters
Sturova, 55
Hlohovec; Trnavsky; Postal Code: 92001

Contact Details: Purchase the G.V.Pharma, A.S. report to view the information.

Basic Information
Total Employees:
Purchase the G.V.Pharma, A.S. report to view the information.
Outstanding Shares:
Purchase the G.V.Pharma, A.S. report to view the information.
Registered Capital:
Purchase the G.V.Pharma, A.S. report to view the information.
Incorporation Date:
June 09, 1995
Key Executives
Purchase this report to view the information.
Chairman of the Board
Purchase this report to view the information.
Member of the Board
Purchase this report to view the information.
Member of the Board
Purchase this report to view the information.
Member of the Supervisory Board
Purchase this report to view the information.
Member of the Supervisory Board
Company Performance
Financial values in the chart are available after G.V.Pharma, A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
145.8%
Total operating revenue
141.08%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total assets
14.27%
Total equity
10.86%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
0.05%
Quick Ratio
-0.96%
Cash Ratio
-0.76%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?